FMI
DGX icon

F/M Investments’s Quest Diagnostics DGX Stock Holding History

F/M Investments’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-12,529
Closed -$1.72M – 343
2024
Q2 		$1.72M Buy
+12,529
New +$1.72M 0.06% 219
2021
Q2 		– Sell
-1,662
Closed -$213K – 76
2021
Q1 		$213K Buy
+1,662
New +$205K 0.17% 80

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DSA
Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Grantham, Mayo, Van Otterloo & Co (GMO)
Grantham, Mayo, Van Otterloo & Co (GMO) Boston, Massachusetts $39.1B AUM 28.69% 1-Year Est. Return

F/M Investments's DGX Position: Q3 2024 in Review

F/M Investments sold out of Quest Diagnostics (DGX) in Q3 2024, closing a stake of 12,529 shares — an estimated $1.72M sold.

F/M Investments first reported a position in DGX in Q1 2021 and held it in 2 quarters. The position peaked at $1.72M in Q2 2024. 846 funds tracked by Wall St. Rank hold DGX as of Q3 2024.

  • F/M Investments reported no remaining Quest Diagnostics position as of Q3 2024 after selling out during the quarter.
  • F/M Investments sold 12,529 Quest Diagnostics shares in Q3 2024, an estimated $1.72M.
  • F/M Investments first reported a position in Quest Diagnostics in Q1 2021 and held it in 2 quarters.
  • F/M Investments's Quest Diagnostics position peaked at $1.72M in Q2 2024.
  • 846 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2024.

Based on F/M Investments's 13F filing for Q3 2024, filed 29 Oct 2024.